UY41009A - Compuestos que se unen la proteína 3i148m que contiene un dominio fosfolipasa tipo patatina y su uso - Google Patents
Compuestos que se unen la proteína 3i148m que contiene un dominio fosfolipasa tipo patatina y su usoInfo
- Publication number
- UY41009A UY41009A UY0001041009A UY41009A UY41009A UY 41009 A UY41009 A UY 41009A UY 0001041009 A UY0001041009 A UY 0001041009A UY 41009 A UY41009 A UY 41009A UY 41009 A UY41009 A UY 41009A
- Authority
- UY
- Uruguay
- Prior art keywords
- compounds
- patatin
- bind
- protein containing
- phospholipase domain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invención se refiere a compuestos de Fórmula (I), y sales e isómeros farmacéuticamente aceptables de dichos compuestos, que se unen a la proteína 3 que contiene un dominio fosfolipidasa tipo patatina (PNPLA3) mutación PNPLA3I148M, (I) composiciones farmacéuticas que comprenden un compuesto de Fórmula (I), o sales farmacéuticamente aceptables del mismo, y su uso en métodos para el tratamiento de enfermedades asociadas con PNPLA3I148M.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363611966P | 2023-12-19 | 2023-12-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY41009A true UY41009A (es) | 2025-07-15 |
Family
ID=94278704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001041009A UY41009A (es) | 2023-12-19 | 2024-12-16 | Compuestos que se unen la proteína 3i148m que contiene un dominio fosfolipasa tipo patatina y su uso |
Country Status (9)
| Country | Link |
|---|---|
| CN (1) | CN122459295A (es) |
| AR (1) | AR134724A1 (es) |
| AU (1) | AU2024406948A1 (es) |
| CO (1) | CO2026008815A2 (es) |
| DO (1) | DOP2026000177A (es) |
| IL (1) | IL328796A (es) |
| TW (1) | TW202542138A (es) |
| UY (1) | UY41009A (es) |
| WO (1) | WO2025133915A1 (es) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0892224A (ja) * | 1994-09-16 | 1996-04-09 | Kumiai Chem Ind Co Ltd | 3,5−置換フェニルトリアゾール誘導体および殺虫、殺ダニ剤 |
| CN113631163A (zh) * | 2019-01-28 | 2021-11-09 | 卡普勒斯疗法有限责任公司 | 包括噻吩中心环的srebp抑制剂 |
-
2024
- 2024-12-16 UY UY0001041009A patent/UY41009A/es unknown
- 2024-12-17 IL IL328796A patent/IL328796A/en unknown
- 2024-12-17 TW TW113149181A patent/TW202542138A/zh unknown
- 2024-12-17 AU AU2024406948A patent/AU2024406948A1/en active Pending
- 2024-12-17 CN CN202480079910.5A patent/CN122459295A/zh active Pending
- 2024-12-17 WO PCT/IB2024/062773 patent/WO2025133915A1/en active Pending
- 2024-12-17 AR ARP240103512A patent/AR134724A1/es unknown
-
2026
- 2026-06-15 DO DO2026000177A patent/DOP2026000177A/es unknown
- 2026-06-16 CO CONC2026/0008815A patent/CO2026008815A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CO2026008815A2 (es) | 2026-06-30 |
| CN122459295A (zh) | 2026-07-24 |
| AU2024406948A1 (en) | 2026-06-11 |
| TW202542138A (zh) | 2025-11-01 |
| IL328796A (en) | 2026-08-01 |
| DOP2026000177A (es) | 2026-07-15 |
| WO2025133915A1 (en) | 2025-06-26 |
| AR134724A1 (es) | 2026-03-04 |